ADAR1 Capital Management »

Rallybio Corp shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Rallybio Corp (RLYB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Rallybio Corp

Tip: Access up to 7 years of quarterly data

All positions including Rallybio Corp held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rallybio Corp by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $184k 21k 8.97

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Rallybio Corp

Viking Global Investors
Cormorant Asset Management
Tpg Gp A
Balyasny Asset Management
Nantahala Capital Management
5AM Venture Management
Almitas Capital
Johnson & Johnson
Vanguard Capital Management
AJU IB Investment
Mariner Wealth Advisors
Geode Capital Management
Deltec Asset Management
Rangeley Capital
ADAR1 Capital Management

View all funds holding Rallybio Corp